Literature DB >> 25287958

Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality.

Uday N Shivaji1, Alexander C Ford1.   

Abstract

AIM: To examine beliefs about irritable bowel syndrome (IBS) management among primary care physicians.
BACKGROUND: There have been considerable advances in evidence synthesis concerning management of IBS in the last five years, with guidelines for its management in primary care published by the National Institute for Health and Care Excellence (NICE).
METHODS: This was a cross-sectional web-based questionnaire survey of 275 primary care physicians. We emailed a link to a SurveyMonkey questionnaire, containing 18 items, to all eligible primary care physicians registered with three clinical commissioning groups in Leeds, UK. Participants were given one month to respond, with a reminder sent out after two weeks.
FINDINGS: One-hundred and two (37.1%) primary care physicians responded. Among responders, 70% believed IBS was a diagnosis of exclusion, and >80% checked coeliac serology often or always in suspected IBS. Between >50% and >70% believed soluble fibre, antispasmodics, peppermint oil, and psychological therapies were potentially efficacious therapies. The respondents were less convinced that antidepressants or probiotics were effective. Despite perceived efficacy of psychological therapies, 80% stated these were not easily available. Levels of use of soluble fibre, antispasmodics, and peppermint oil were in the range of 40% to >50%. Most primary care physicians obtained up-to-date evidence about IBS management from NICE guidelines. Most primary care physicians still believe IBS is a diagnosis of exclusion, and many are reluctant to use antidepressants or probiotics to treat IBS. More research studies addressing diagnosis and treatment of IBS based in primary are required.

Entities:  

Keywords:  antidepressants; antispasmodics; coeliac disease; fibre; irritable bowel syndrome; probiotics

Mesh:

Substances:

Year:  2014        PMID: 25287958     DOI: 10.1017/S1463423614000383

Source DB:  PubMed          Journal:  Prim Health Care Res Dev        ISSN: 1463-4236            Impact factor:   1.458


  9 in total

1.  Rational investigations in irritable bowel syndrome.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2019-06-06

2.  Making a positive diagnosis of irritable bowel syndrome.

Authors:  Ruchit Sood; Robbie Foy; Alexander C Ford
Journal:  Br J Gen Pract       Date:  2017-12       Impact factor: 5.386

3.  Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.

Authors:  Sarah L Alderson; Alexandra Wright-Hughes; Alexander C Ford; Amanda Farrin; Suzanne Hartley; Catherine Fernandez; Christopher Taylor; Pei Loo Ow; Emma Teasdale; Daniel Howdon; Elspeth Guthrie; Robbie Foy; Matthew J Ridd; Felicity L Bishop; Delia Muir; Matthew Chaddock; Amy Herbert; Deborah Cooper; Ruth Gibbins; Sonia Newman; Heather Cook; Roberta Longo; Hazel Everitt
Journal:  Trials       Date:  2022-07-08       Impact factor: 2.728

4.  Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.

Authors:  Massimo Bellini; Cesare Tosetti; Francesco Rettura; Riccardo Morganti; Christian Lambiase; Gabrio Bassotti; Pierfrancesco Visaggi; Andrea Pancetti; Edoardo Benedetto; Nicola de Bortoli; Paolo Usai-Satta; Rudi De Bastiani
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

Review 5.  Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education.

Authors:  Albena Halpert
Journal:  J Clin Med       Date:  2018-01-02       Impact factor: 4.241

6.  Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Gregory S Sayuk; Ray Wolf; Lin Chang
Journal:  Am J Gastroenterol       Date:  2017-01-17       Impact factor: 10.864

7.  Noninvasive Diagnosis of Irritable Bowel Syndrome via Bowel Sound Features: Proof of Concept.

Authors:  Xuhao Du; Gary Allwood; K Mary Webberley; Andrisha-Jade Inderjeeth; Adam Osseiran; Barry James Marshall
Journal:  Clin Transl Gastroenterol       Date:  2019-03       Impact factor: 4.488

8.  Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past.

Authors:  Ruchit Sood; Alexander C Ford
Journal:  Clin Transl Gastroenterol       Date:  2015-10-08       Impact factor: 4.488

9.  The daily practice of (suspected) coeliac disease management by general practitioners: A qualitative approach.

Authors:  Tom van Gils; Talha G Senler; Henriëtte E van der Horst; Chris J J Mulder; Gerd Bouma; Henk de Vries
Journal:  Eur J Gen Pract       Date:  2018-12       Impact factor: 1.904

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.